Market Indices
Latest News
 |
Tigo Energy, Inc. (TYGO) confirmed earnings release on February 24, 2026,...
February 23, 2026 TYGO -1.78% |
| ||
| ||
| ||
|
Price Targets
from Robert W. Baird issued a price target of $18.00 for LIFE on 2026-02-23 09:41:00.The adjusted price target was set to $18.00.At the time of the announcement,
February 23, 2026
Ross Sandler from Piper Sandler issued a price target of $20.00 for LIFE on 2026-02-23 06:57:00.The adjusted price target was set to $20.00.At the time of the announcement,
February 23, 2026
Matt Bryson from Wedbush issued a price target of $28.00 for AXTI on 2026-02-20 13:22:33.The adjusted price target was set to $28.00.At the time of the announcement, AXTI...
February 20, 2026 AXTI -4.45%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| VNDA Vanda Pharmaceuticals Inc | 8.18
42.01% | ||||||||||||||||||
| ASPS Altisource Portfolio Solu | 6.70
24.48% | ||||||||||||||||||
| TELA TELA Bio, Inc. | 0.82
14.30% | ||||||||||||||||||
| VOR Vor Biopharma Inc. | 15.44
13.95% | ||||||||||||||||||
| CDIOW Cardio Diagnostics Holdin | 0.03
11.20% | ||||||||||||||||||
| SPRB Spruce Biosciences, Inc. | 55.27
11.15% | ||||||||||||||||||
| PFX PhenixFIN Corporation | 46.83
10.96% | ||||||||||||||||||
| ONCY Oncolytics Biotech Inc. | 1.07
10.83% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -2.58%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -3.32%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 6.59%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN -3.33%